Andrews Ronald Asbury's Form 4 filing
Insight Molecular Diagnostics Inc. (IMDX) · filed Mar 17, 2022
- Accession no.
- 0001493152-22-007205
- Filed
- Mar 17, 2022
- Trade date
- Mar 16, 2022
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market purchases total $64.0K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Andrews Ronald AsburyCIK 0001299153 | Director, Officer (Chief Executive Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 16, 2022 | Common Stock, no par value | PPurchaseAcquired | +50,000 | $1.28 | +$64,000 | 293,212 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.